Clinical Trials Logo

Filter by:
NCT ID: NCT05704751 Not yet recruiting - Clinical trials for Back Pain Lower Back Chronic

EVOKE ECAP-Controlled Lead Placement and Programming in Chronic Pain Patients

ECAP
Start date: November 1, 2023
Phase:
Study type: Observational

This study is designed to evaluate the feasibility of using intra-operative ECAP and Late-Response (LR) recordings for confirmation of activating the neuronal target of the dorsal column in a single-stage SCS lead placement procedure. The collected ECAP and LR data will be analysed post-hoc to further evaluate its utility for determining the laterality of lead placement with respect to the physiologic midline of the dorsal column.

NCT ID: NCT05702840 Completed - Clinical trials for Overweight and Obesity

EXerCise wEight Loss

EXCEL
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The overall aim of this study is to investigate the effects of home-based resistance exercise programme on changes in body composition and strength during weight loss, in people living with obesity or overweight.

NCT ID: NCT05702684 Recruiting - Colorectal Cancer Clinical Trials

Personalised Cancer Care and Support: Identifying What Good Looks Like

Start date: July 31, 2023
Phase:
Study type: Observational

The overarching aim is to study the coproduction of personalised care in a digital age by seeking to improve the experience of care and personalised care and support planning for people who live with and beyond colorectal cancer. This study will assess digital health contributions to personalised care and explore how to improve the quality of collaborative digital care planning in cancer services. The electronic holistic needs assessment (eHNA) developed by Macmillan Cancer Support (macmillan.org.uk/healthcare-professionals/innovation-in-cancer-care/holistic-needs-assessmen t/sign-up-to-ehna) will be used as a case study to help advance this aspect of healthcare improvement studies. The primary objective is to gain a better understanding of how personalised care and support planning in the form of the eHNA and consultation works (or not) from the perspectives of people who are living with and beyond colorectal cancer, and clinicians. The secondary objectives are to: i. identify what good practice looks like for digital personalised care and support planning in a specific tumour group (colorectal) and at a point in the cancer pathway (within 31 days of diagnosis) ii. explore if the ARC framework can be used to inform personalised cancer care and support planning The research will review current practice and focus on identifying what good looks like for digital cancer care planning. It will go on to explore how what we know about LWBC can be used to inform the co-design of digital care planning that better supports personalised long-term cancer care. From the outset, this early work will help to inform future issues around generalisability and scaling-up.

NCT ID: NCT05702619 Recruiting - Prostate Cancer Clinical Trials

Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)

HYPROGEN
Start date: October 3, 2021
Phase:
Study type: Observational

Due to the rapid growth, tumour demand for oxygen is often higher than what can be delivered by the newly forming blood vessels. Tumour adaption to this imbalanced oxygen supply and demand (hypoxia) is associated with poor prognosis and genetic changes (genomic instability) that allow it to become more resistant to chemo- and radiotherapy. Patients with hypoxic tumours therefore die earlier. Limited information is available on hypoxia in newly diagnosed prostate cancer, especially to what degree hypoxia in the prostate tumour is associated with the presence of metastases to bones. The Hyprogen trial is a prospective, non-randomised, exploratory biopsy and imaging biomarker study recruiting 60 patients with prostate cancer to better establish the role of hypoxia in prostate cancer cells evolution and early metastatic spread.

NCT ID: NCT05702294 Recruiting - Healthy Clinical Trials

Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries .

e-BLaDR
Start date: September 14, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to give an answer to the question of whether an automated calculation of voided volumes would produce a more accurate set of bladder diary data when compared to the traditional ''eye-balling'' method of estimated voided volumes of paper bladder diaries, in female adult patients with lower urinary tract symptoms (LUTS). The main question[s] it aims to answer are: - Does an automated measurement of voided volumes improve the accuracy of bladder diary data? - Does an automated measurement of voided volumes improve the utility of bladder diaries? Participants will be asked to: - void in the disposable measuring jug and record their estimated voided volume for a total of three consecutive days in a paper diary (as per usual care). - transfer their voided volume from the disposable jug to the automated vessel (diary pod) after each void for the same three consecutive days. The reports generated from the paper diaries (estimated volumes) will be compared to the reports generated from the electronic automated measurement of voided volumes to understand whether there is a clinically significant difference between the two. The investigators aim to recruit healthy female adult volunteers with no lower urinary tract symptoms to understand the normal voiding patterns and volumes of adult females using the diary pod. The investigators will also recruit adult females with lower urinary tract symptoms and compare the two methods of capturing the voided volume

NCT ID: NCT05702229 Recruiting - Gastric Cancer Clinical Trials

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Start date: January 16, 2023
Phase: Phase 2
Study type: Interventional

This is a Phase II, open-label, multi-drug, multi-centre study designed to assess the efficacy, safety, tolerability, pharmacokinetics, and immunogenicity of novel combination therapies in participants with locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma.

NCT ID: NCT05702034 Recruiting - Clinical trials for Ischemic Stroke; Ischemic Attack, Transient

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

LIBREXIA-STROK
Start date: February 15, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

NCT ID: NCT05701917 Recruiting - Clinical trials for Venous Thromboembolism

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

DEFIANCE
Start date: January 6, 2023
Phase: N/A
Study type: Interventional

This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.

NCT ID: NCT05701774 Active, not recruiting - Clinical trials for Prader-Willi Syndrome

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

Start date: January 31, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.

NCT ID: NCT05701670 Completed - Anxiety Clinical Trials

Intervention Package to Promote Emotion Regulation Strategies in University Students

Start date: January 30, 2023
Phase: N/A
Study type: Interventional

The primary aim of the proposed Randomised Control study is to investigate the effects of a socially assisted robot (i.e. Purrble) and a co-designed, bespoke Single Session Intervention (SSI) on students' anxiety (GAD-7) over the period of the two academic terms (in comparison to a wait-listed student group). Secondary aims include investigating the effects of the Purrble and SSI on students' emotion regulation processes, depressive symptoms, and quantitative and qualitative (interviews) measures of engagement with the intervention.